Selective Radioprotection of Normal Tissues by Nanoparticles: Antioxidants as Radioprotectors, Radiation's Negative Effects, and New Approaches to Radioprotection

Authors

  • Safa Abd Yasir Abdullah Jasim, Shahad Ali Hussein, Ali Abbas Abed Jebur, Zeina Haider Abd AL-Rahman, Mukhtar Yassin Jabbar Attia Al-Hilla University College, Department of Medical Physics, Iraq

Keywords:

Nanoparticles, Selective Radioprotection, Normal Tissues

Abstract

Ionising radiation is used in radiation therapy to destroy cancer cells; nevertheless, there are negative side effects to this treatment. The harmful effects of radiation on healthy tissue can be mitigated with the use of some radioprotective medications. Multifunctional nanoparticles have recently gained a lot of attention due to the growing interest in nanotechnology in the biological sciences. These particles serve multiple purposes, including improving molecular radioprotective drugs through improved drug delivery systems and opening up new avenues for the development of radioprotective agents, as some nanoparticles already have these properties. When used to the medical field, nanotechnology is known as nanomedicine. In its most fundamental form, nanomedicine refers to two ideas. On the one hand, it's described as a field that applies molecular tools and human body knowledge to medical diagnosis and treatment. On the other hand, it's described as the application of physical effects on nanoscale objects at the interface of the molecular and macroscopic worlds, where quantum mechanics is taken for granted. The late Nobel laureate physicist Richard P. Feynman was the first to express his vision for the numerous medical uses of nanotechnology; he foresaw the implantation of microscopic surgical robots. By bringing together nanotechnology and biology, we can solve many biomedical problems and transform healthcare, as the vast majority of natural processes occur at the nanoscale. Nanoscale inorganic and organic particles can be biologically modified to serve as a sensor, imaging tool, gene delivery system, artificial implant, targeted drug delivery, and other medical applications.

Downloads

Download data is not yet available.

References

Curtis A and Wilkinson C. Nanotechniques and approaches in biotechnology. Trends in Biotechnology.2001;19:97-101.

Waren CW and Nie S. Quantum dot bioconjugates for ultra-sensitive nonisotopic detection. Science.1998;281:2016-2018.

Vaseashta A and Dimova-Malinovska D. Nanostructured and nanoscale devices, sensors and detectors.Science and Technology of Advanced Materials. 2005;6:312-318.

Langer R. Drug delivery: drugs on target. Science. 2001;293:58- 59. 8. Roy K, Mao HQ, Huang SK andLeong KW. Oral gene delivery with Chitosan-DNA nanoparticles generates immunologic protection in amurine model of peanut allergy. Nature Medicine. 1999;5:387- 391.

Sachlos E, Gotora D and Czernuszka JT. Collagen scaffolds reinforced with biomimetic composite nano-sizedcarbonatesubstituted hydroxyapatite crystals and shaped by rapid prototyping to contain internalmicrochannels. Tissue engineering. 2006;12:2479-2487

Karbownik M and Reiter RJ. Antioxidative Effects of Melatonin in Protection Against Cellular DamageCaused by Ionizing Radiation. Proceedings of the Society for Experimental Biology and Medicine. 2000; 225:9-22.

United Nations Scientific Committee on the Effects of Atomic Radiation (2000). "Annex C: Exposures to thepublic from manmade sources of radiation". Sources and Effects of Ionizing Radiation. New York, NY:United Nations Publications. pp. 157–291. ISBN 978-92-1-142238-2.

Nair CK, Parida DK and Nomura T. Radioprotectors in radiotherapy. Journal of Radiation Research.2001;42:21-37.

Gonzalez AB and Darby S. Risk of Cancer from Diagnostic X rays, Estimate for UK and 14 Other Countries,The Lancet. 2004;363:345-351.

Brenner DJ and Elliston CD. Estimated Radiation Risks Potentially Associated with Full Body CT Screening,Radiology. 2004;232:735-738.

Seed TM. Radiation protectants: current status and future prospects. Health Physics. 2005;89:531-45.

Hoffmann GR, Buccola J and Merz MS. Structure-activity analysis of the potentiation by aminothiols of thechromosome-damaging effect of bleomycin in G0 human lymphocytes. Environmental and MolecularMutagenesis. 2001;37:117–127.

Weiss JF and Landauer MR. Protection against ionizing radiation by antioxidant nutrients andphytochemicals. Toxicology. 2003;189:1-20.

Mettler FAJ and Voelz GL. Major radiation exposure : what to expect and how to respond. The New EnglandJournal of Medicine. 2002;346:1554-1561.

Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluatingagents intended for the prophylaxis, mitigation and treatment of radiation injuries. Radiation Research.2004;162:711-728.

McBride WH, Chiang CS, Olson JL. Wang CC, Hong JH and Pajonk F. A sense of danger from radiation.Radiat. Res. 2004;162:1-19.

Kroto HW, Heath JP, O'Brien SC, Curl RF and Smalley RE. C60: Buckminsterfullerene. Nature.1985;318:162-163.

Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson H and Moussa F. Fullerene is an in vivo powerfulantioxidant with no acute or sub-acute toxicity. Nano Letters 2005;5:2578-85.

Nielsen GD, Roursgaard M, Jensen KA, Poulsen SS and Larsen ST. In vivo biology and toxicology offullerenes and their derivates. Basic & Clinical Pharmacology & Toxicology. 2008;103:197-208.

Krusic PJ, Wasserman E, Keizer PN, Morton JR and Preston KF. Science. 1991;254:1183-85.

Ali SS, Hardt JI, Quick KL, Kim-Han JS, Erlanger BF, Huang TT, et al. Free. Radic. Biol. Med.2004;37:1191-1202

Guldi DM, Asmus KD. Activity of water-soluble fullerenes towards . radical OH-radicals and molecularoxygen. Radiation Physics and Chemistry. 1999;56:449-456.

Cheng F, Yang X, Zhu H, Sun J and Liu Y. Synthesis of oligoadducts of malonic acid C and their scavengingeffects on hydroxyl radical. 60 Journal of Physics and Chemistry of Solids. 2000;61:1145-1148.

Sun T, Jia Z, Xu Z. Different hydroxyl radical scavenging activity of water-soluble â-alanine C60 adducts.Bioorganic & Medicinal Chemistry Letters. 2004;14:1779-1781.

Wang IC, Tai LA, Lee DD, Kanakamma PP, Shen CKF., Luh TY, et al. C60 and Water-Soluble FullereneDerivatives as Antioxidants against Radical-Initiated Lipid Peroxidation. Journal of Medicinal Chemistry.1999;42:4614-4620.

Alili, L., M. Sack, A. S. Karakoti, S. Teuber, K. Puschmann, S. M. Hirst et al. 2011. Combined cytotoxic andanti-invasive properties of redox-active nanoparticles in tumor–stroma interactions. Biomaterials 32:2918–2929.

Das, M., S. Patil, N. Bhargava, J. F. Kang, L. M. Riedel, S. Seal et al. 2007. Auto-catalytic ceria nanoparticlesoffer neuro- protection to adult rat spinal cord neurons. Biomaterials 28:1918–1925.

Dugan, L. L., D. M. Turetsky, C. Du, D. Lobner, M. Wheeler, C. R. Almli et al. 1997. Carboxyfullerenes asneuroprotective agents. Proceedings of the National Academy of Sciences of the United States of America94:9434–9439.

Dugan, L. L., E. G. Lovett, K. L. Quick, J. Lotharius, T. T. Lin, and K. L. O’Malley. 2001. Fullerene-basedantioxidants and neurodegenerative disorders. Parkinsonism and Related Disorders 7:243–246.

Hamm, B., T. Staks, M. Taupitz, R. Maibauer, A. Speidel, A. Huppertz et al. 1994. Contrast-enhanced MRimaging of liver and spleen: First experience in humans with a new superparamagnetic iron oxide. Journal ofMagnetic Resonance Imaging 4:659–668.

Harisinghani, M. G., J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa et al. 2003.Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New England Journal ofMedicine 348:2491–2499.

Harrington, K. J., G. Rowlinson-Busza, K. N. Syrigos, P. S. Uster, R. M. Abra, and J. S. Stewart. 2000.Biodistribution and phar- macokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumourxenograft model: Implications for novel targeting strategies. British Journal of Cancer 83:232–238.

Heckert, E. G., S. Seal, and W. T. Self. 2008. Fenton-like reaction catalyzed by the rare earth inner transitionmetal cerium. Environmental Science and Technology 42:5014–5019.

Hirst, S. M., A. S. Karakoti, R. D. Tyler, N. Sriranganathan, S. Seal, and C. M. Reilly. 2009. Anti-inflammatory properties of cerium oxide nanoparticles. Small 5:2848–2856.

Lucente-Schultz, R. M., V. C. Moore, A. D. Leonard, B. K. Price, D. V. Kosynkin, M. Lu et al. 2009.Antioxidant single-walled carbon nanotubes. Journal of the American Chemical Society 131:3934–3941.

Martin, R., C. Menchon, N. Apostolova, V. M. Victor, M. Alvaro, J. R. Herance et al. 2010. Nano-jewels inbiology. Gold and platinum on diamond nanoparticles as antioxidant systems against cellular oxidative stress.ACS Nano 4:6957–6965.

Matsumura, Y., and H. Maeda. 1986. A new concept for macro-molecular therapeutics in cancerchemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. CancerResearch 46:6387–6392.

McLachlan, S. J., M. R. Morris, M. A. Lucas, R. A. Fisco, M. N. Eakins, D. R. Fowler et al. 1994. Phase Iclinical evaluation of a new iron oxide MR contrast agent. Journal of Magnetic Resonance Imaging 4:301–307.

Montet, X., R. Weissleder, and L. Josephson. 2006. Imaging pancreatic cancer with a peptide–nanoparticleconjugate targeted to normal pancreas. Bioconjugate Chemistry 17:905–911.

Murray, D., and W. H. McBride. 1996. Radioprotective agents. In: Kirk-OthmerEncyclopedia of ChemicalTechnology, edited by J. I. Kroschwitz, and M. Howe-Grant, 963–1006. New York: John Wiley & Sons.

Quick, K. L., S. S. Ali, R. Arch, C. Xiong, D. Wozniak, and L. L. Dugan. 2008. A carboxyfullerene SODmimetic improves cognition and extends the lifespan of mice. Neurobiology of Aging 29:117–128.

Reimer, P., and T. Balzer. 2003. Ferucarbotran (Resovist): A new clinically approved RES-specific contrastagent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. EuropeanRadiology 13:1266–1276.

Riehemann, K., S. W. Schneider, T. A. Luger, B. Godin, M. Ferrari, and H. Fuchs. 2009. Nanomedicine—challenge and perspectives. Angewandte Chemie International Edition in English 48:872–897.

Ryan, J. L., S. Krishnan, B. Movsas, C. N. Coleman, B. Vikram, and S. S. Yoo. 2011. Decreasing the adverseeffects of cancer therapy: An NCI workshop on the preclinical development of radiation injurymitigators/protectors. Radiation Research 176:688–691.

Schubert, D., R. Dargusch, J. Raitano, and S. W. Chan. 2006. Cerium and yttrium oxide nanoparticles areneuro-protective. Biochemical and Biophysical Research Communications 342:86–91.

Schweitzer, A. D., R. C. Howell, Z. Jiang, R. A. Bryan, G. Gerfen, C. C. Chen et al. 2009. Physico-chemicalevaluation of rationally designed melanins as novel nature-inspired radioprotectors. PLoS One 4:e7229.

Schweitzer, A. D., E. Revskaya, P. Chu, V. Pazo, M. Friedman, J. D. Nosanchuk et al. 2010. Melanin-coverednanoparticles for protection of bone marrow during radiation therapy of cancer. International Journal ofRadiation Oncology, Biology, Physics 78:1494–1502.

Seeney, T. R. 1979. A Survey of Compounds from the Antiradiation Drug Development Program of the U.S.Army Medical Research Development Command. Walter Reed Army Inst. of Research. U.S. Army MedicalResearch Development Command, Washington, D.C. Spencer, C. M., and K. L. Goa. 1995.

Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as aradioprotector and cytotoxic chemoprotector. Drugs 50:1001–1031.

Tarnuzzer, R. W., J. Colon, S. Patil, and S. Seal. 2005. Vacancy engineered ceria nanostructures for protectionfrom radiation-induced cellular damage. Nano Letters 5:2573–2577.

Weiss, J. F., and M. R. Landauer. 2009. History and development of radiation-protective agents. InternationalJournal of Radiation Biology 85:539–573.

Weissleder, R., D. D. Stark, B. L. Engelstad, B. R. Bacon, C. C. Compton, D. L. White et al. 1989.Superparamagnetic iron-oxide: Pharmacokinetics and toxicity. American Journal of Roentgenology 152:167–173.

Williams, J. P., S. L. Brown, G. E. Georges, M. Hauer-Jensen, R. P. Hill, A. K. Huser et al. 2010. Animalmodels for medical countermeasures to radiation exposure. Radiation Research 173:557–578.

Downloads

Published

2024-07-19

How to Cite

Zeina Haider Abd AL-Rahman, Mukhtar Yassin Jabbar Attia, S. A. Y. A. J. S. A. H. A. A. A. J. (2024). Selective Radioprotection of Normal Tissues by Nanoparticles: Antioxidants as Radioprotectors, Radiation’s Negative Effects, and New Approaches to Radioprotection. Current Clinical and Medical Education, 2(07), 82–91. Retrieved from https://www.visionpublisher.info/index.php/ccme/article/view/132

Issue

Section

Articles